0001127602-21-021194.txt : 20210702
0001127602-21-021194.hdr.sgml : 20210702
20210702160119
ACCESSION NUMBER: 0001127602-21-021194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Perry Nicole D
CENTRAL INDEX KEY: 0001657874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 211069822
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-07-01
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657874
Perry Nicole D
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Vice President - Accounting
Common Stock
2021-07-01
4
M
0
1000
3.76
A
5847
D
Common Stock
2021-07-01
4
S
0
1000
64.00
D
4847
D
Stock Option (Right to Buy)
3.76
2021-07-01
4
M
0
1000
0
D
2025-07-31
Common Stock
1000
7161
D
This is a scheduled exercise from a 10B5-1 trading plan.
This option was granted on July 31, 2015 and is fully vested.
/s/ David Watson, attorney-in-fact for Nicole Perry
2021-07-02